Corvus Pharmaceuticals, Inc.
CRVS
Revenue
0.00
0.000.00%
-Assets
68.91M
▲10.09M▲17.16%
3 Months ChangeLiabilities
36.34M
▼-10.07M▼-21.69%
3 Months ChangeFree Cash Flow
-8.15M
▲861.00k▲9.56%
48 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-23
Form 8-K
ID: 0001558370-24-013518
2024-08-06
Form 10-Q
ID: 0001558370-24-011076
2024-08-06
Form 8-K
ID: 0001171843-24-004479
2024-06-14
Form 8-K
ID: 0001171843-24-003444
2024-05-07
Form 10-Q
ID: 0001558370-24-007093
2024-05-06
Form 8-K
ID: 0001193125-24-131920
2024-05-06
Form 8-K
ID: 0001171843-24-002569
2024-05-01
Form 8-K
ID: 0001193125-24-127611
2024-03-19
Form 8-K
ID: 0001171843-24-001454
2024-01-23
Form 8-K
ID: 0001171843-24-000360